Gain Therapeutics Inc (GANX) stock is lower by -31.49% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives GANX stock a score of 35 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 8. GANX's rank also includes a short-term technical score of 22. GANX has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on GANX!